HomeInsightsDividend

Take Solutions Ltd dividend

Take Solutions Ltd dividend

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

43.8 K

stocks traded

Last Updated time: 20 Jul 9.00 AM

Image

Take Solutions Ltd

NSE: TAKE

DPS

--

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Take Solutions Ltd is ₹ 0 as of 2023 .a1#The Dividend Payout of Take Solutions Ltd changed from 85 % on March 2019 to 0 % on March 2023 . This represents a CAGR of -100.00% over 5 years. a1#The Latest Trading Price of Take Solutions Ltd is ₹ 20.28 as of 19 Jul 15:30 .a1#The Market Cap of Take Solutions Ltd changed from ₹ 2215 crore on March 2019 to ₹ 199.86 crore on March 2023 . This represents a CAGR of -38.19% over 5 years. a1#The Revenue of Take Solutions Ltd changed from ₹ 62.4 crore to ₹ 13.27 crore over 8 quarters. This represents a CAGR of -53.88% a1#The EBITDA of Take Solutions Ltd changed from ₹ -20.14 crore to ₹ -107 crore over 8 quarters. This represents a CAGR of 131.54% a1#The Net Pr of Take Solutions Ltd changed from ₹ -26.35 crore to ₹ -110 crore over 8 quarters. This represents a CAGR of 104.88% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Take Solutions Ltd

Market Cap

300 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

0.0

DTE *

-4.2

ROE *

308.9

ROCE *

-70.1

Dividend Yield *

0

DPS *

0

Dividend Payout *

0

Ann.Dividend % *

0

* All values are consolidated

Last Updated time: 20 Jul 9.00 AM

* All values are consolidated

Last Updated time: 20 Jul 9.00 AM

×

Historical Dividend Payout of Take Solutions Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Take Solutions Ltd

Period
Mar '1985
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Take Solutions Ltd

NSE: TAKE

PRICE

20.28

-0.18 (-0.88%)

stock direction

Last updated : 19 Jul 15:30

SWOT Analysis Of Take Solutions Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Take Solutions Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Take Solutions Ltd

Period
Mar '192215
Mar '20587
Mar '21665
Mar '22428
Mar '23200

* All values are a in crore

×

Historical Revenue of Take Solutions Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Take Solutions Ltd

Period
Jun '2262
Sep '2267
Dec '2252
Mar '2336
Jun '2318
Sep '2318
Dec '2318
Mar '2413

* All values are a in crore

×

Historical EBITDA of Take Solutions Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Take Solutions Ltd

Period
Jun '22-20
Sep '22-3
Dec '22-3
Mar '23-48
Jun '23-1
Sep '232
Dec '232
Mar '24-108

* All values are a in crore

×

Historical Net Profit of Take Solutions Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Take Solutions Ltd

Period
Jun '22-26
Sep '22-8
Dec '22-10
Mar '23-56
Jun '23-5
Sep '23-2
Dec '23-2
Mar '24-111

* All values are a in crore

About Take Solutions Ltd

About Take Solutions Ltd

    The Company was incorporated as a private limited company by the name TAKE Solutions Private Limited on December 20, 2000. The company has been promoted by a team of domain experts in the supply chain management sector of the software industry. TAKE Solutions delivers domain-intensive services and solutions in Life Sciences, Software and Information Technology. In the fast-growing Life Sciences space, the Company offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, the Company delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE through its subsidiaries focuses on niche engineering services, supply chain collaboration and product re-engineering. Its IP-led approach enables clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. Pursuant to a Scheme of Amalgamation, a company namely, Millennium Infocomm Limited was merged with Company w.e.f. January 1, 2003 i.e. the Appointed Date and the Scheme of Amalgamation came into effect on February 23, 2004. On February 7 2003, the company has acquired the divisions/softwares of iStartWeb Private Limited and MSIPL. The division of iStartWeb Private Limited, dealt with BPM, workflow management, application and information integration. The division of MSIPL had capabilities in secondary sales management software. In December 2003, the company has acquired fifty-one (51%) of the equity share capital of Megatrends Limited but subsequently on April 5, 2005 the company has divested equity fully in Megatrends and this company ceased to be our subsidiary. On November 20, 2004, the company has incorporated a wholly owned Subsidiary in the Kingdom of Bahrain by the name of TAKE Solutions Gulf W.L.L. This Subsidiary has enabled to foray in the Middle East markets for marketing SCM suite of products. However, TAKE Solutions Gulf W.L.L. has now been voluntarily liquidated by the Company w.e.f. January 22, 2007. In the year 2004-2005, the company has developed a suite of products across the SCM vertical, which enabled to deliver customized business solutions and support services at shrink-wrap speeds to clients. In December 2005, the company has acquired majority stake in the equity of TAKE Inc. then a subsidiary company of TAKE Solutions Pte Limited (one of our Promoters). In March 2006, the company has acquired the entire shareholding of TAKE Inc. USA and thereby Company forayed into the US markets. The acquisition also added a new vertical i.e. the Life Sciences Space known as Life Sciences Technology Solutions' having a suite of products under the brand umbrella 'OneClinical'. In 2006, TAKE Inc launched the software product PharmaReady in the Life Sciences space. TAKE Inc. further has a subsidiary namely Applied Clinical Intelligence L.L.C. On 29th March 2006, the company has acquired 58.06% in the equity of Autopartsasia Private Limited, which is a 100% EOU in India. This acquisition enabled to extend SCM model in the automotive space of the industry. On 31st March 2006, the company has acquired 97.75% in the equity of Millennium Business Solutions (Sdn) Bhd., Malaysia from Millenium Business Solutions Private Limited, India. By way of this acquisition company has forayed into the South East Asian market for marketing SCM suite of products. The company has entered into a Shareholders Agreement dated June 1, 2006 with United Integrated Sdn Bhd, Malaysia for converting this company into a joint venture wherein Company shall hold fifty one percent (51%) equity capital and the rest will be held by United Integrated Sdn Bhd, Malaysia. Pursuant this agreement, the name of the company has been changed to TAKE United Sdn Bhd w.e.f. July 7, 2006. The conversion of the company into a joint venture has not yet been given effect to. In March 2007, the company has acquired the entire share capital of CMNK Consultancy & Services Private Limited. In June 2007, the company has acquired ClearOrbit Inc. USA, a Delaware Corporation; through USA based subsidiary TAKE Inc. ClearOrbit is now the wholly owned subsidiary of TAKE Solutions Inc. During FY 2015, TAKE 10 Solutions Private Limited, India was divested and TAKE Intellectual Properties Management Inc., USA was merged with its parent company Navitas Inc, USA. During the year 2018, the Company allotted 14,697,200 equity shares of Rs 1 each at an issue price of Rs 170.10 per equity share (including a Share Premium of Rs 169.10 per share) on Preferential basis to TAKE Solutions Pte Ltd. (Promoter of the Company) on March 22, 2018 after obtaining the necessary approvals, including In-Principle approvals from both National Stock Exchange and Bombay Stock Exchange. During the year 2018, the Company disinvested its entire stake held in Towell TAKE Solutions LLC; Muscat (Joint Venture with Towell) on March 28, 2018 for a consideration of USD 2,000,000. Further the step down subsidiaries under Towell TAKE Investments LLC, Muscat (Towell TAKE Solutions LLC, Muscat , TAKE Solutions MEA Limited, Dubai and Mirnah Technologies Systems Limited, Saudi Arabia) also got disinvested in the process. During FY 2018, the Company had given loan amounting to Rs 573.15 million to its wholly owned subsidiary M/s. Ecron Acunova Limited (f.k.a. Manipal Acunova Limited) and Rs 208.23 million to TAKE Solutions Global Holdings PTE Ltd. In FY18, TAKE launched an ICH E6 (R2) Readiness Assessment Framework to help industry players become proactively compliant with the latest requirements to run successful clinical trials. To augment its breadth of knowledge and deepen expertise, the Company initiated the institution of a Medical & Scientific Advisory Board. It further leveraged its domain knowledge and technology expertise to launch OneClinical, an eClinical platform to the market. OneClinical delivers near real-time, high-quality data and optimizes clinical trials. Proven across a variety of global trials, the platform offers short setup time with low fixed costs, and provides global accessibility with near real-time data analytics and visualizations. In FY 2018, the Engineering Services sub-vertical added another offering that enables compliance across the industry. The Green Check Software Platform helps companies assess their supply chains to ensure they meet the requirement of the Safe Drinking Water and Toxic Enforcement Act, also known as Proposition 65, of the State of California, USA. In FY 2017-18, TAKE invested in its infrastructure across geographies. The Company inaugurated a state-of-the-art, 80-bedded clinical facility in Chennai to cater the growing demand for high quality clinical trials. It expanded the facilities in Bangalore, Princeton and Bogota to take advantage of exciting market opportunities across Asia, Europe and North and South America. During Q4 FY 2018, one of the Supply Chain subsidiaries of the Company, Towell TAKE Investments LLC was disinvested. During the year, Company disposed its supply chain unit, TAKE Supply Chain in Austin USA held by Navitas Inc, a wholly owned subsidiary, to ESM Capital, LLC, USA on September 28, 2019, for a consideration of USD 3.25 million. The Company acquired two US based entities namely KAI Holdings Inc, a CRO & health research company and Dataceutics Holdings Inc, a specialty Clinical Functional Service provider for a consideration of USD 27 million and USD 45 million respectively in FY 2019. Navitas Life Sciences Inc, USA, a wholly owned subsidiary merged into Navitas Inc, USA, a wholly owned subsidiary, with effect from February 25, 2019. Astus Technologies Inc, USA, TAKE Dataworks Inc, USA and TAKE Synergies Inc, USA, wholly owned subsidiaries merged into TAKE Innovations Inc, USA, a wholly owned subsidiary with effect from February 22, 2019. KAI Holdings Inc and Dataceutics Holdings Inc. merged with Navitas Inc, USA and TAKE Innovations Inc, USA, respectively with effect from May 06, 2019.In FY19, the Company however, re-classified its business activity from Computer Programming, Consultancy and Related Activities to Scientific Research and Development, so as to represent the main area of activity of the Company. During FY 2019, the Company provided loan amounting to Rs 1028.26 Million to its wholly owned subsidiary M/s. Ecron Acunova Limited and Rs 121.24 million to TAKE Solutions Global Holdings Pte Ltd. During FY 2019, the Company converted its loan amount of USD 20.46 Million provided to TAKE Solutions Global Holding PTE LTD, Singapore (a wholly owned subsidiary) on various dates into equity shares of SGD Shares 3.60 Million at a rate of SGD 7.7213 per share.

Take Solutions Ltd News Hub

News

Take Solutions to convene AGM

Take Solutions announced that the 23rd Annual General Meeting (AGM) of the company will be...

Read more

01 Jul 202419:34

News

Take Solutions declare Quarterly Result

Take Solutions will hold a meeting of the Board of Directors of the Company on 30 May 2024...

Read more

21 May 202412:13

News

Take Solutions to declare Quarterly Result

Take Solutions will hold a meeting of the Board of Directors of the Company on 13 February...

Read more

29 Jan 202417:27

News

Take Solutions to announce Quarterly Result

Take Solutions will hold a meeting of the Board of Directors of the Company on 8 November ...

Read more

06 Nov 202313:39

News

Take Solutions to conduct board meeting

Take Solutions will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

10 Aug 202316:59

News

Take Solutions to conduct AGM

Take Solutions announced that the 22th Annual General Meeting (AGM) of the company will be...

Read more

19 Jul 202310:25

FAQs for dividends of Take Solutions Ltd

What is the current market price of Take Solutions Ltd Ltd as of July 20, 2024?

The current market price of Take Solutions Ltd Ltd stands at 20.3 per share.

What dividend did Take Solutions Ltd declare in the last fiscal year?

In the last fiscal year, Take Solutions Ltd declared a dividend totaling ₹0.0.

What is the most recent dividend declared by Take Solutions Ltd?

Take Solutions Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Take Solutions Ltd declared dividends in the current fiscal year

Take Solutions Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Take Solutions Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Take Solutions Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199